Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
68
SRPT Quote, Financials, Valuation and Earnings
Last price:
$46.80
Seasonality move
:
16.21%
Day range:
$46.52 - $63.92
52-week range:
$48.01 - $173.25
Dividend yield:
0%
P/E ratio:
27.92x
P/S ratio:
3.73x
P/B ratio:
4.04x
Volume:
2.1M
Avg. volume:
2.4M
1-year change:
-52.37%
Market cap:
$6.2B
Revenue:
$1.9B
EPS (TTM):
$2.28
SRPT Analysts' Consensus Rating
The 18 analysts providing 12-month price projections for Sarepta Therapeutics shares anticipate an average target of $147.33, ranging from a low estimate of $70.00 to a high estimate of $209.00. This average target implies a growth of 131.44% compared to the current stock price of $63.66.
Consensus Price Target
$147.33
Highest Price Target
$209.00
Lowest Price Target
$70.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 12 | 14 | 14 |
| Hold | 0 | 4 | 4 |
| Sell | 1 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
SRPT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
